Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease

Authors

Caitlin M. Neri, George Washington University
Sophie R. Pestieau, George Washington UniversityFollow
Deepika S. Darbari, Children's National Medical Center, Washington, DCFollow

Document Type

Response or Comment

Publication Date

8-2013

Journal

Paediatric Anaesthesia

Volume

Volume 23, Issue 8

Inclusive Pages

684-689

Keywords

Anemia, Sickle Cell--complications; Anesthetics, Dissociative--therapeutic use; Arterial Occlusive Diseases--complications; Excitatory Amino Acid Antagonists--therapeutic use; Ketamine--therapeutic use; Pain--drug therapy

APA Citation

Neri, C. M., Pestieau, S. R., & Darbari, D. S. (2013). Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease. Paediatric Anaesthesia, 23(8), 684-689.

Peer Reviewed

1